ReviewBMC veterinary research2026
Advances in paratuberculosis research and control: a comprehensive expert review.
Review in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review summarizes the 2025 update of the DISCONTOOLS gap analysis for Paratuberculosis, which was based on scientific literature review combined with expert knowledge. It summarizes recent advances across key areas including diagnostics, epidemiology, pathogenesis, vaccination, genetic resistance and alternative therapies. Progress in understanding host-pathogen interactions and immune responses is highlighted alongside developments in diagnostic tools such as molecular assays and phage-based detection. Vaccination strategies continue to evolve with efforts to improve efficacy and reduce interference with bovine Tuberculosis testing. Genetic studies reveal certain heritability of resistance traits, supporting breeding programs as complementary control measures. Alternative therapies including antibodies, mycobacteriophages, and probiotics show promise for early-life infection management. This review also addresses potential public health implications mostly related to the association with Crohn's disease. Despite advances, significant knowledge gaps persist, emphasizing the need for advanced control strategies or therapies to effectively manage Paratuberculosis in ruminants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.